Novavax, Inc. (NVAX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 04:00PM EDT. Market open.
| Previous close | 51.43 |
| Open | 52.13 |
| Bid | 57.00 x 800 |
| Ask | 57.05 x 1800 |
| Day's range | 50.88 - 57.55 |
| 52-week range | 34.88 - 277.80 |
| Volume | |
| Avg. volume | 6,201,855 |
| Market cap | 4.321B |
| Beta (5Y monthly) | 1.33 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -14.95 |
| Earnings date | 28 Feb 2022 - 04 Mar 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 183.40 |
- Motley Fool
It's a Bear Market, but Is This Stock in Even More Trouble?
Indeed, the S&P 500 is in bear market territory, defined as a 20% (or more) drop from its most recent high. Take biotech company Novavax (NASDAQ: NVAX). While the broader market sell-off hasn't helped Novavax, the company has encountered its own issues, too.
- Zacks
Novavax (NVAX) Stock Moves -0.81%: What You Should Know
In the latest trading session, Novavax (NVAX) closed at $51.43, marking a -0.81% move from the previous day.
- Yahoo Finance
Omicron: Experts want more data to guide US targeting of fall boosters
The FDA is asking COVID-19 vaccine makers to test and produce boosters that target both the original and new BA.4/BA.5 strains of the virus by fall.
© 2022 Yahoo. All rights reserved.
